Knowles Corporation reported strong Q1 2026 results, with total revenue of $153 million, a 16% increase year-over-year, and earnings per share (EPS) of $0.27, up 50%. The performance was driven by robust demand in both the MedTech and Specialty Audio segment, which generated $68 million in revenue, and the Precision Devices segment, which brought in $85 million. Notably, the company’s gross margins improved significantly, reaching 53.5% for MedTech and Specialty Audio, and 39.2% for Precision Devices, reflecting enhanced pricing strategies and operational efficiencies.
This growth trajectory is significant for market professionals, as Knowles is not only exceeding its revenue guidance but also showing a strong book-to-bill ratio of 1.19, indicating sustained demand. The company anticipates continued organic growth, particularly in the Precision Devices segment, supported by a favorable outlook in defense, medical, and industrial markets.
Investors should note the upward revision in revenue growth expectations for 2026, now projected to exceed the previously communicated range of 4% to 6%, highlighting Knowles’ solid positioning amid favorable market trends.
Source: fool.com